Prson Gautam

9PUBLICATIONS
67CO-AUTHORS
Molecular targetsCancer diagnosisCheminformatics and quantitative structure-activity relationshipsPredictive and prognostic markersCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 06, 2024
Defining the KRAS- and ERK-dependent transcriptome in KRAS-mutant cancers.

Jeffrey A Klomp, Jennifer E Klomp, Clint A Stalnecker

|Dec 18, 2021
Concurrent Inhibition of IGF1R and ERK Increases Pancreatic Cancer Sensitivity to Autophagy Inhibitors.

Clint A Stalnecker, Kajal R Grover, A Cole Edwards

|Jun 19, 2021
CIP2A Interacts with TopBP1 and Drives Basal-Like Breast Cancer Tumorigenesis.

Anni Laine, Srikar G Nagelli, Caroline Farrington

|Feb 20, 2021
Patient-tailored design for selective co-inhibition of leukemic cell subpopulations.

Aleksandr Ianevski, Jenni Lahtela, Komal K Javarappa

|Dec 28, 2020
Multiobjective optimization identifies cancer-selective combination therapies.

Otto I Pulkkinen, Prson Gautam, Ville Mustonen

|Dec 02, 2020
Leveraging multi-way interactions for systematic prediction of pre-clinical drug combination effects.

Heli Julkunen, Anna Cichonska, Prson Gautam

Pageof 2